{"DataElement":{"publicId":"7789408","version":"1","preferredName":"Prostate Gland Precancerous Condition Histopathologic Examination Outcome","preferredDefinition":"The subtype of prostate carcinoma defined by the microscopic and cytologic tissue abnormality characteristics.","longName":"7789396v1.0:7789403v1.0","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"7789396","version":"1","preferredName":"Prostate Gland Precancerous Condition Histopathologic Examination","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen._A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia._The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"2320019v1.0:6753443v1.0","context":"MCL","contextVersion":"1","ObjectClass":{"publicId":"2320019","version":"1","preferredName":"Prostate","preferredDefinition":"A gland in the male reproductive system just below the bladder. It surrounds part of the urethra, the canal that empties the bladder. It produces a fluid that forms part of semen. (NCI-GLOSS)","longName":"C12410","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC6EF0D8-50A9-6865-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6753443","version":"1","preferredName":"Precancerous Condition Histopathologic Examination","preferredDefinition":"Pathological processes that tend eventually to become malignant. (From Dorland, 27th ed):The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","longName":"C3341:C18190","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histopathologic Examination","conceptCode":"C18190","definition":"The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8863001C-C2AC-5839-E053-F662850AD2A9","latestVersionIndicator":"Yes","beginDate":"2019-05-08","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-05-08","modifiedBy":"ONEDATA","dateModified":"2019-05-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD125FB0-9EEC-6CFC-E053-4EBD850A2144","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"COLBERTM","dateModified":"2022-02-28","changeDescription":"2/28/22 mr Released per SME.   9/28/21 mr Created for MCL prostate.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7789403","version":"1","preferredName":"Prostate Gland Precancerous Condition Histopathologic Examination Type","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen._A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia._The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains._Something distinguishable as an identifiable class based on common qualities.","longName":"7789403v1.0","context":"MCL","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3ADD-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682953","version":"1","preferredName":"Unknown","longName":"5682953","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B4645-0FC6-0802-E053-F662850AB305","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-01-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3AE7-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3AF1-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"High grade prostatic intraepithelial neoplasia (HGPIN)/ (PIN II & PIN III)","valueDescription":"High Grade Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"2581149","version":"1","preferredName":"High Grade Prostatic Intraepithelial Neoplasia","longName":"2581149","preferredDefinition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts. The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoloplasmic ratio. The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform. The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Prostatic Intraepithelial Neoplasia","conceptCode":"C5541","definition":"Prostatic intraepithelial neoplasia characterized by the presence of morphologically malignant cells lining the acini and ducts.  The malignant cells are enlarged, contain prominent nucleoli, and have increased nuclear/cytoplasmic ratio.  The malignant cells may grow within the ducts and acini in four architectural patterns: flat, tufting, micropapillary, and cribriform.  The presence of high grade prostatic intraepithelial neoplasia in needle biopsy is a risk factor for the subsequent detection of carcinoma on repeat biopsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0A0A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"DWARZEL","dateModified":"2006-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3B06-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"Low grade prostatic intraepithelial neoplasia (PIN)/ (PIN I)","valueDescription":"Low Grade Prostatic Intraepithelial Neoplasia","ValueMeaning":{"publicId":"3918249","version":"1","preferredName":"Low Grade Prostatic Intraepithelial Neoplasia","longName":"3918249","preferredDefinition":"Prostatic intraepithelial neoplasia characterized by the proliferation of secretory cells with irregular spacing in the ducts and acini.  Although some proliferating epithelial cells may contain prominent nucleoli, the cytologic atypia and architectural growth patterns that are seen in the high grade prostatic intraepithelial neoplasia are absent.  The presence of low grade prostatic intraepithelial neoplasia in needle biopsy is not a risk factor for the subsequent detection of carcinoma on repeat biopsy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Prostatic Intraepithelial Neoplasia","conceptCode":"C5542","definition":"Prostatic intraepithelial neoplasia characterized by the proliferation of secretory cells with irregular spacing in the ducts and acini.  Although some proliferating epithelial cells may contain prominent nucleoli, the cytologic atypia and architectural growth patterns that are seen in the high grade prostatic intraepithelial neoplasia are absent.  The presence of low grade prostatic intraepithelial neoplasia in needle biopsy is not a risk factor for the subsequent detection of carcinoma on repeat biopsy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E8673FC8-BC44-9D61-E040-BB89AD431A7D","latestVersionIndicator":"Yes","beginDate":"2013-10-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-10-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3B1A-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"Atypical adenomatous hyperplasia (adenosis or AAH)","valueDescription":"Prostatic Atypical Adenomatous Hyperplasia","ValueMeaning":{"publicId":"2577202","version":"1","preferredName":"Prostatic Atypical Adenomatous Hyperplasia","longName":"2577202","preferredDefinition":"A prostatic hyperplasia characterized by the presence of crowded adenomatous epithelial nodules.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostatic Atypical Adenomatous Hyperplasia","conceptCode":"C5595","definition":"A prostatic hyperplasia characterized by the presence of crowded adenomatous epithelial nodules.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA9F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-23","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-11-23","modifiedBy":"COOPERM","dateModified":"2019-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3B2F-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"Clear cell cribiform hyperplasia","valueDescription":"Prostatic Cribriform Hyperplasia","ValueMeaning":{"publicId":"7789405","version":"1","preferredName":"Prostatic Cribriform Hyperplasia","longName":"7789405","preferredDefinition":"A rare type of prostatic hyperplasia. It is characterized by hyperplastic glandular cells with clear cytoplasm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostatic Clear Cell Cribriform Hyperplasia","conceptCode":"C5594","definition":"A rare type of prostatic hyperplasia. It is characterized by hyperplastic glandular cells with clear cytoplasm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD136857-3B3D-36A7-E053-4EBD850A80BA","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3B56-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"},{"value":"Basal cell hyperplasia","valueDescription":"Prostatic Basal Cell Hyperplasia","ValueMeaning":{"publicId":"7789407","version":"1","preferredName":"Prostatic Basal Cell Hyperplasia","longName":"7789407","preferredDefinition":"A type of prostatic hyperplasia.  It is characterized by the presence of nodules of dark basal cells around residual prostatic secretory cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostatic Basal Cell Hyperplasia","conceptCode":"C5593","definition":"A type of prostatic hyperplasia.  It is characterized by the presence of nodules of dark basal cells around residual prostatic secretory cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD136857-3B63-36A7-E053-4EBD850A80BA","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CD136857-3B7C-36A7-E053-4EBD850A80BA","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7789402","version":"1","preferredName":"Prostate Gland Precancerous Condition Histopathologic Examination Type","preferredDefinition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.:A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.:The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.:Something distinguishable as an identifiable class based on common qualities.","longName":"C12410:C3341:C18190:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prostate Gland","conceptCode":"C12410","definition":"The walnut shaped accessory sex gland of the male reproductive system. It is located in the pelvis just below the bladder, surrounding the prostatic part of the urethra. The prostate gland secretes a fluid which is part of the semen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Precancerous Condition","conceptCode":"C3341","definition":"A pathological process with signs indicating it may become cancerous.  Representative examples include leukoplakia, dysplastic nevus, actinic keratosis, xeroderma pigmentosum, and intraepithelial neoplasia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histopathologic Examination","conceptCode":"C18190","definition":"The microscopic study of characteristic tissue abnormalities by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CD136857-3AB5-36A7-E053-4EBD850A80BA","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"ONEDATA","dateModified":"2021-09-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD136857-3AC6-36A7-E053-4EBD850A80BA","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"COLBERTM","dateModified":"2022-03-01","changeDescription":"3/1/22 mr Released per SME.   9/28/21 mr Created for MCL prostate.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506113","version":"1","longName":"Prostate","context":"MCL","ClassificationSchemeItems":[{"publicId":"7781145","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001794","version":"1","longName":"Prostate PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"morphologic_cytologic_subtypes","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Morphologic and cytologic sub","type":"Preferred Question Text","description":"Morphologic and cytologic subtypes","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"prostate_v0_13aug2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"CD13802F-0DA5-1A66-E053-4EBD850A409B","latestVersionIndicator":"Yes","beginDate":"2021-09-28","endDate":null,"createdBy":"COLBERTM","dateCreated":"2021-09-28","modifiedBy":"COLBERTM","dateModified":"2022-02-24","changeDescription":"2/24/22 mr Released per SME.   10/26/21 mr Edited definition.  10/13/21 mr Edited definition.   9/28/21 mr Created for MCL prostate per MCL DD.  Added ref doc, CSI.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}